Corient Private Wealth’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.8M | Buy |
99,739
+12,865
| +15% | +$1.01M | 0.01% | 629 |
|
|
2025
Q1 | $6.3M | Sell |
86,874
-7,192
| -8% | -$521K | 0.01% | 622 |
|
|
2024
Q4 | $6.96M | Sell |
94,066
-13,886
| -13% | -$1.03M | 0.01% | 608 |
|
|
2024
Q3 | $7.12M | Sell |
107,952
-32,830
| -23% | -$2.17M | 0.01% | 634 |
|
|
2024
Q2 | $13M | Sell |
140,782
-4,811
| -3% | -$444K | 0.02% | 468 |
|
|
2024
Q1 | $13.9M | Buy |
145,593
+7,762
| +6% | +$742K | 0.02% | 459 |
|
|
2023
Q4 | $10.5M | Sell |
137,831
-13,440
| -9% | -$1.02M | 0.02% | 506 |
|
|
2023
Q3 | $10.5M | Buy |
151,271
+761
| +0.5% | +$52.7K | 0.02% | 467 |
|
|
2023
Q2 | $14.2M | Buy |
150,510
+68,667
| +84% | +$6.48M | 0.03% | 410 |
|
|
2023
Q1 | $6.77M | Buy |
81,843
+2,443
| +3% | +$202K | 0.02% | 510 |
|
|
2022
Q4 | $5.95M | Buy |
+79,400
| New | +$5.95M | 0.02% | 459 |
|